OPKO Health Sees Q3 Sales $131.000M-$142.000M vs $134.650M Est

Benzinga Newsdesk www.benzinga.com Positive 76.3%

Neg 0% Neu 0% Pos 76.3%

OPKO Health (NASDAQ:OPK) sees Q3 sales of $131.000 million-$142.000 million vs $134.650 million analyst estimate.

Comments

No comments yet. Be the first!